Ledger.Open graph →
SEC Form D · Amendment · filed November 2, 2022

Elicio Therapeutics, Inc

Offering
$50.0M
Sold
$22.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Daphne Karydas · Boston, MADirectorAntonio Salgado · Long Beach, NYExec · DirectorDaniel Hilson · ANN ARBOR, MIDirectorMarc Jordan · Encino, CADirectorAnthony Brasher · ANN ARBOR, MIDirectorYekaterina Chudnovsky · Boston, MADirectorDaniel Geffken · Boston, MAExec · DirectorAssaf Segal · Boston, MADirectorChristophe Seywert · Grand Duchy of Luxembourg, LuxembourgDirectorKelly Anderson · Wichita, KSExec · DirectorJared Champlin · Dallas, TXExec · DirectorJulian Adams · Boston, MADirectorThomas Hulick · Pasadena, CADirectorYekaterina Chudnovsky · Boston, MADirectorMark Disiena · Wichita, KSExecEllen R. Reilly · CHELSEA, MAExecChristopher Haqq · Boston, MAExecJulian R. Marcu · CHELSEA, MADirectorGrant Begley · Wichita, KSDirectorRobert Connelly · Boston, MAExec · DirectorAssaf Segal · Boston, MADirectorH. M. Chambers · Leeds, ALDirectorJohn Dunkelberger · Eden Prairie, MNExec · DirectorRobert Ruffolo · Boston, MADirectorAnnette Matthies · Boston, MAExecThomas Gardner · Wichita, KSExecCarol Ashe · Boston, MADirectorThomas Mallon · INCLINE VILLAGE, NVExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗